The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
A partial deficiency of interleukin-7Rα is sufficient to abrogate T-cell development and cause severe combined immunodeficiency
Abstract
Both in vitro and in vivo studies established that interleukin 7 (IL-7) is essential for differentiation of immature T cells and B cells but not natural killer (NK) cells in the mouse. In humans, although both T-cell and B-cell progenitors express the functional IL-7 receptor that consists of IL-7R alpha and the gamma common (gamma c) chain, this lymphocyte receptor system is critical for T lineage but not for B lineage development. Indeed, complete gamma c deficiency like IL-7R alpha deficiency results in the arrest of T-cell but not B-cell development (T(-)B(+) SCID). However, partial deficiency of gamma c caused by missense mutations results in a T(+)B(+) phenotype and a delay of clinical presentation. It was therefore plausible to assume that partial deficiency of IL-7R alpha, like partial gamma c deficiency may lead to a milder clinical and immunologic phenotype. A P132S mutation in the IL-7R alpha was identified in 3 patients with severe combined immunodeficiency (SCID) within an extensively consanguineous family. Substitution of proline with serine in the extracellular portion of IL-7R alpha did not affect IL-7R alpha messenger RNA (mRNA) and protein expression, but severely compromised affinity to IL-7, resulting in defective signal transduction. In response to IL-7 stimulation, Jak-3 phosphorylation was markedly reduced in both patient cells as well as in COS cells reconstituted with mutant IL-7R alpha. Surprisingly, this partial deficiency of IL-7R alpha resulted in a severe phenotype, including markedly reduced circulating T cells while sparing B-cell numbers similar to gamma c chain deficiency. However, unlike the previously reported cases, serum immunoglobulins were virtually absent. Further, unlike gamma c deficiency, NK cell numbers and function was preserved. Despite the partial deficiency, clinical presentation was indistinguishable from a complete gamma c deficiency, including severe and persistent viral and protozoal infections and failure to thrive. Unlike partial gamma c deficiency, a partial deficiency of IL-7R alpha results in an arrest of T-cell development, leading to typical severe combined immunodeficiency. This underscores the critical role of IL-7R alpha chain in the differentiation of T cells. (Blood. 2000;96:2803-2807)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in the IL-7Rα or γc in humans lead to severe combined immunodeficiency, confirming the importance of the IL-7 signaling pathway in the development of T cells (158, 159).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [159]
Citations
Cites
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,338
Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Cao, X., Shores, E. W., Hu‐Li, J., Anver, M. R., Kelsail, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90047-0 · Cited by 1,039
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
Macchi, P., VILLA, A. M., Giliani, S. C., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Sheai, J. J., et al. (1995) · Nature · doi:10.1038/377065a0 · Cited by 871
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
Santo, J. P. D., Müller, W., Guy‐Grand, D., Fischer, A., & Rajewsky, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.377 · Cited by 866
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
Puel, A., Ziegler, S. F., Buckley, R. H., & Leonard., W. J. (1998) · Nature Genetics · doi:10.1038/3877 · Cited by 813
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T., Noguchi, M., Markert, M. L., Buckley, R. H., et al. (1995) · Science · doi:10.1126/science.270.5237.797 · Cited by 801
Defective Lymphoid Development in Mice Lacking Jak3
Nosaka, T., van Deursen, J. M. A., Tripp, R. A., Thierfelder, W. E., Witthuhn, B. A., McMickle, A., Doherty, P. C., Grosveld, G. C., & Ihle, J. N. (1995) · Science · doi:10.1126/science.270.5237.800 · Cited by 637
Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3
Thomis, D. C., Gurniak, C. B., Tivol, E. A., Sharpe, A. H., & Berg, L. J. (1995) · Science · doi:10.1126/science.270.5237.794 · Cited by 537
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
Park, S., Saijo, K., Takahashi, T., Osawa, M., Areas, H., Hirayama, N., Miyake, K., Nakauchi, H., Shirasawa, T., & Saito, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90066-7 · Cited by 487
Early T Lymphocyte Progenitors
Shortman, K., & Wu, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.29 · Cited by 448
Cited by
Sorted by citations
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., & Weissman, I. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141007 · Cited by 1,025
Aiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02247 · Cited by 693
Buckley, R. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104614 · Cited by 526
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Bernstein, I. L., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Kobrynski, L. J., Levinson, A. I., Mazer, B. D., Nelson, R. P., et al. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61142-8 · Cited by 516
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
Zenatti, P. P., Ribeiro, D., Li, W., Zuurbier, L. C., da Silva, M. C., Paganin, M., Tritapoe, J. M., Hixon, J. A., Silveira, A. B., Cardoso, B. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.924 · Cited by 426
Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells
Reche, P. A., Soumelis, V., Gorman, D. M., Clifford, T., Liu, M.-R., Travis, M. A., Zurawski, S., Johnston, J., Liu, Y.-J., Spits, H., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.336 · Cited by 402
Bone marrow and the control of immunity
Zhao, E., Xu, H., Wang, L., Kryczek, I., Wu, K., Hu, Y., Wang, G., & Zou, W. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.47 · Cited by 367
Müller‐Sieburg, C. E., Cho, R. H., Karlsson, L., Huang, J.-F., & Sieburg, H. B. (2004) · Blood · doi:10.1182/blood-2003-10-3448 · Cited by 309
The science and medicine of human immunology
Pulendran, B., & Davis, M. M. (2020) · Science · doi:10.1126/science.aay4014 · Cited by 275
Human NK cells can control CMV infection in the absence of T cells
Kuijpers, T. W., Baars, P. A., Dantin, C., van der Burg, M., van Lier, R. A. W., & Roosnek, E. E. (2008) · Blood · doi:10.1182/blood-2008-05-157354 · Cited by 240
Dadi, H., Simon, A. J., & Roifman, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031178 · Cited by 214
Self-citationGiliani, S. C., Mori, L., Basile, G. D. S., Deist, F. L., Rodriguez‐Pérez, C., Forino, C., Mazzolari, E., Dupuis, S., Elhasid, R., Kessel, A., et al. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00234.x · Cited by 175
Barata, J. T., Cardoso, A. A., Nadler, L. M., & Boussiotis, V. A. (2001) · Blood · doi:10.1182/blood.v98.5.1524 · Cited by 173
IL-7 in human health and disease
Lundström, W., Fewkes, N. M., & Mackall, C. L. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.02.005 · Cited by 158
Lin, J., & Leonard, W. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041447 · Cited by 150
Distinct Regions of the Interleukin-7 Receptor Regulate Different Bcl2 Family Members
Jiang, Q., Li, W., Hofmeister, R., Young, H. A., Hodge, D. R., Keller, J. R., Khaled, A. R., & Durum, S. K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6501-6513.2004 · Cited by 139
Roberts, J. L., Lengi, A. J., Brown, S. M., Chen, M., Zhou, Y., O’Shea, J. J., & Buckley, R. H. (2003) · Blood · doi:10.1182/blood-2003-06-2104 · Cited by 136
Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs
Pesu, M., Candotti, F., Husa, M., Hofmann, S. R., Notarangelo, L. D., & O’Shea, J. J. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00220.x · Cited by 135
12. Primary immunodeficiency diseases
Bonilla, F. A., & Geha, R. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.86 · Cited by 134
Winer, H. Y., Rodrigues, G. O. L., Hixon, J. A., Aiello, F. B., Hsu, T. C., Wachter, B. T., Li, W., & Durum, S. K. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156049 · Cited by 136
Unravelling the association of partial T-cell immunodeficiency and immune dysregulation
Liston, A., Enders, A., & Siggs, O. M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2336 · Cited by 125
Jak3 and the pathogenesis of severe combined immunodeficiency
OASHEA, J. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.014 · Cited by 121
Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk
Galarza-Muñoz, G., Briggs, F. B. S., Evsyukova, I. Y., Schott, G., Kennedy, E. M., Nyanhete, T. E., Wang, L., Bergamaschi, L., Widen, S. G., Tomaras, G. D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.007 · Cited by 124
Lang, J., Kelly, M., Freed, B. M., McCarter, M. D., Kedl, R. M., Torres, R. M., & Pelanda, R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202810 · Cited by 116
Rajasuriar, R., Booth, D. R., Solomon, A. E., Chua, K., Spelman, T. D., Gouillou, M., Schlub, T. E., Davenport, M. P., Crowe, S. M., Elliott, J., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656369 · Cited by 116
Sasson, S. C., Zaunders, J. J., Zanetti, G., King, E. M., Merlin, K., Smith, D. E., Stanley, K. K., Cooper, D. A., & Kelleher, A. D. (2006) · The Journal of Infectious Diseases · doi:10.1086/499309 · Cited by 115
Update on Chlamydia trachomatis Vaccinology
de la Maza, L. M., Zhong, G., & Brunham, R. C. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00543-16 · Cited by 117
Parrish, Y. K., Báez, I., Milford, T.-A. M., Benitez, A., Galloway, N., Rogerio, J. W., Sahakian, E., Kagoda, M., Huang, G., Hao, Q., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800489 · Cited by 104
Teutsch, S. M., Booth, D. R., Bennetts, B., Heard, R. N., & Stewart, G. J. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200994 · Cited by 99
Severe Combined Immunodeficiency Disorders
Chinn, I. K., & Shearer, W. T. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.07.002 · Cited by 93
Correa‐Rocha, R., Pérez, A., Lorente, R., Ferrando‐Martínez, S., Leal, M., Gurbindo, D., & Muñoz‐Fernández, M. Á. (2012) · Pediatric Research · doi:10.1038/pr.2012.6 · Cited by 93
Roberts, J. L., Lauritsen, J. P. H., Cooney, M., Parrott, R. E., Sajaroff, E. O., Win, C. M., Keller, M. D., Carpenter, J. H., Carabaña, J., Krangel, M. S., et al. (2006) · Blood · doi:10.1182/blood-2006-08-043166 · Cited by 86
Storek, J., Gillespy, T., Lu, H., Joseph, A., Dawson, M. A., Gough, M., Morris, J. C., Hackman, R. C., Horn, P. A., Sale, G. E., et al. (2003) · Blood · doi:10.1182/blood-2002-08-2671 · Cited by 84
Thymic Atrophy: Experimental Studies and Therapeutic Interventions
Majumdar, S., & Nandi, D. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12618 · Cited by 84
Thymic stromal lymphopoietin induces early human B‐cell proliferation and differentiation
Scheeren, F. A., van Lent, A. U., Nagasawa, M., Weijer, K. C., Spits, H., Legrand, N., & Blom, B. (2010) · European Journal of Immunology · doi:10.1002/eji.200939419 · Cited by 78
Ellsworth, S. G., Balmanoukian, A. S., Kos, F. J., Nirschl, C. J., Nirschl, T. R., Grossman, S. A., Luznik, L., & Drake, C. G. (2014) · OncoImmunology · doi:10.4161/onci.27357 · Cited by 83
The human IL-7 receptor gene: Deletions, polymorphisms and mutations
Mazzucchelli, R. I., Riva, A., & Durum, S. K. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.02.007 · Cited by 78
Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis
Raza, S. M., Fuller, G. N., Rhee, C. H., Huang, S., Hess, K. R., Zhang, W., & Sawaya, R. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0155-3 · Cited by 74
T cell development, ageing and Interleukin-7
Aspinall, R. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.016 · Cited by 71
Pike‐Overzet, K., de Ridder, D., Weerkamp, F., Baert, M. R. M., Verstegen, M. M. A., Brugman, M. H., Howe, S. J., Reinders, M. J. T., Thrasher, A. J., Wagemaker, G., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404563 · Cited by 70
IL-7 Enhances Survival of Human CD56bright NK Cells
Michaud, A., Dardari, R., Charrier, E., Cordeiro, P., Herblot, S., & Duval, M. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181cd872d · Cited by 69
Zubkova, I., Mostowski, H. S., & Zaitseva, M. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2321 · Cited by 62
Lum, J. J., Schnepple, D. J., Nie, Z., Sanchez-Dardon, J. L., Mbisa, G. L., Mihowich, J., Hawley‐Foss, N., Narayan, S., Kim, J. E., Lynch, D. H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6033-6042.2004 · Cited by 59
Keystones in lymph node development
Blum, K. S., & Pabst, R. (2006) · Journal of Anatomy · doi:10.1111/j.1469-7580.2006.00650.x · Cited by 58
Bayer, D. K., Martinez, C. A., Sorte, H. S., Forbes, L. R., Demmler‐Harrison, G. J., Hanson, I. C., Pearson, N. M., Noroski, L. M., Zaki, S. R., Bellini, W. J., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12421 · Cited by 57
The genetic basis of severe combined immunodeficiency and its variants
Dalal, I., & Tasher (2012) · The Application of Clinical Genetics · doi:10.2147/tacg.s18693 · Cited by 59
Iwanami, N., Mateos, F., Hess, I., Riffel, N., Soza‐Ried, C., Schorpp, M., & Boehm, T. L. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003907 · Cited by 58
Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia
Bayón-Calderón, F., Toribio, M. L., & González-García, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207685 · Cited by 62
Regulatory mechanisms of thymus and T cell development
Ma, D., Wei, Y., & Liu, F. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.12.013 · Cited by 60
Abnormal interleukin-7 function in common variable immunodeficiency
Holm, A. M., Aukrust, P., Damås, J. K., Müller, F., Halvorsen, B. L., & Frøland, S. S. (2004) · Blood · doi:10.1182/blood-2004-06-2423 · Cited by 54
Morre, M., & Beq, S. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0210-4 · Cited by 51
Shamim, Z., Ryder, L. P., Heilmann, C. J., MADSEN, H. O., Lauersen, H., Andersen, P. K., Svejgaard, A., Jacobsen, N. O., & Müller, K. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705277 · Cited by 50
Gene expression alterations in activated human T-cells induced by modeled microgravity
Ward, N. E., Pellis, N. R., Risin, S. A., & Risin, D. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20988 · Cited by 47
Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia
Tal, N., Shochat, C., Geron, I., Bercovich, D., & Izraeli, S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1337-x · Cited by 48
Sasson, S. C., Smith, S. A. B. C., Seddiki, N., Zaunders, J. J., Bryant, A. J., Koelsch, K. K., Weatherall, C. J., Munier, C. M. L., McGinley, C., Yeung, J. Y. K., et al. (2010) · Cytokine · doi:10.1016/j.cyto.2009.12.001 · Cited by 45
IL-7–dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL
Barata, J. T., Boussiotis, V. A., Yunes, J. A., Ferrando, A. A., Moreau, L. A., Veiga, J. P., Sallan, S. E., Look, A. T., Nadler, L. M., & Cardoso, A. A. (2003) · Blood · doi:10.1182/blood-2002-12-3861 · Cited by 45
Ferrando‐Martínez, S., Lorente, R., Gurbindo, D., de José, M. I., Leal, M., Muñoz‐Fernández, M. Á., & Correa‐Rocha, R. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.12.013 · Cited by 44
Study of the association between the CAPSL-IL7R locus and type 1 diabetes
Santiago, J. L., Alizadeh, B. Z., Martínez, A., Espino‐Paisán, L., de la Calle, H., Fernández‐Arquero, M., Figueredo, M. A., de la Concha, E. G., Roep, B. O., Koeleman, B. P. C., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1070-4 · Cited by 44
Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic
Healy, L. M., Yaqubi, M., Ludwin, S. K., & Antel, J. P. (2019) · Glia · doi:10.1002/glia.23746 · Cited by 41
Cooper, M. A., Pommering, T. L., & Koranyi, K. I. (2008) · Springer eBooks · doi:10.1007/978-3-540-33395-1_22 · Cited by 44
Overexpression of IL-7Rα provides a competitive advantage during early T-cell development
Laouar, Y., Crispe, I., & Flavell, R. (2004) · Blood · doi:10.1182/blood-2003-06-2126 · Cited by 42
Faller, E., Sugden, S., McVey, M. J., Kakal, J. A., & MacPherson, P. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902207 · Cited by 40
Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia?
Morimoto, M., Myung, C., Beirnes, K., Choi, K., Asakura, Y., Bökenkamp, A., Bonneau, D., Brugnara, M., Charrow, J., Colin, E., et al. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0519-7 · Cited by 39
Update on primary immunodeficiency: defects of lymphocytes
Simonte, S. J., & Cunningham‐Rundles, C. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00183-9 · Cited by 39
Integrative Analyses of Genes Associated with Hashimoto’s Thyroiditis
Qiu, K., Li, K., Zeng, T., Liao, Y., Min, J., Zhang, N., Peng, M., Kong, W., & Chen, L. (2021) · Journal of Immunology Research · doi:10.1155/2021/8263829 · Cited by 38
Fuchs, S. P., Rensing‐Ehl, A., Erlacher, M., Vraetz, T., Hartjes, L., Janda, A., Rizzi, M., Lorenz, M. R., Gilmour, K. C., Basile, G. D. S., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201444689 · Cited by 35
Self-citationInherited disorders of cytokines
Pïcard, C., & Casanova, J. (2004) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000145919.92477.5f · Cited by 35
Leone, A. K., Rohankhedkar, M., Okoye, A. A., Legasse, A. W., Axthelm, M. K., Villinger, F. J., Piatak, M., Lifson, J. D., Assouline, B., Morre, M., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902626 · Cited by 34
Wang, X., Chang, S., Wang, T., Wu, R., Huang, Z., Sun, J., Liu, J., Yu, Y., & Mao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857289 · Cited by 34
Epigenetic Maintenance of Acquired Gene Expression Programs during Memory CD8 T Cell Homeostasis
Abdelsamed, H. A., Zebley, C. C., & Youngblood, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00006 · Cited by 33
Kalle, C. V., Fehse, B., Layh‐Schmitt, G., Schmidt, M., Kelly, P. F., & Baum, C. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.07.007 · Cited by 33
Deleterious and Oncogenic Mutations in the IL7RA
Campos, L. W., Pissinato, L. G., & Yunes, J. A. (2019) · Cancers · doi:10.3390/cancers11121952 · Cited by 30
Menkova, I., Hocini, H., Foucat, E., Tisserand, P., Bourdery, L., Delaugerre, C., Benne, C., Lévy, Y., & Lelièvre, J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005571 · Cited by 31
Roifman, C. M. (2004) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200412000-00002 · Cited by 29
Self-citationSanyal, M., Morimoto, M., Baradaran‐Heravi, A., Choi, K., Kambham, N., Jensen, K. P., Dutt, S., Dionis, K. Y., Liu, L. X., Felix, K., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.10.005 · Cited by 28
Autoimmune manifestations in SCID due to IL7R mutations: Omenn syndrome and cytopenias
Zago, C. A., Jacob, C. M. A., Diniz, E. M. D. A., Lovisolo, S. M., Zerbini, M. C. N., Dorna, M. D. B., Watanabe, L. A., Fernandes, J. F., Rocha, V., Oliveira, J. B., et al. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.04.006 · Cited by 28
Functionally Distinct Subpopulations of CpG-Activated Memory B Cells
Henn, A. D., Laski, M., Yang, H., Welle, S. L., Qiu, X., Miao, H., Barry, C. T., Wu, H., & Zand, M. S. (2012) · Scientific Reports · doi:10.1038/srep00345 · Cited by 28
Liongue, C., Ratnayake, T., Basheer, F., & Ward, A. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052977 · Cited by 28
Genome-wide association studies in multiple sclerosis: lessons and future prospects
Kemppinen, A., Sawcer, S. J., & Compston, A. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr004 · Cited by 27
Ciupe, S. M., Devlin, B. H., Markert, M. L., & Kepler, T. B. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000396 · Cited by 26
Saha, P., Bose, D., Stebliankin, V., Cickovski, T., Seth, R. K., Porter, D. E., Brooks, B. W., Mathee, K., Narasimhan, G., Colwell, R. R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15708-3 · Cited by 26
TLR Ligand-Induced Type I IFNs Affect Thymopoiesis
Baron, M., Gauchat, D., Motte-Mohs, R. N. L., Kettaf, N., Abdallah, A., Michiels, T., Zúñiga‐Pflücker, J. C., & Sékaly, R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7134 · Cited by 24
Functional NK Cell Repertoires Are Maintained through IL-2Rα and Fas Ligand
Felices, M., Lenvik, T. R., Ankarlo, D., Foley, B. A., Curtsinger, J., Luo, X., Blazar, B. R., Anderson, S. K., & Miller, J. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302601 · Cited by 22
Faller, E., Ghazawi, F. M., Cavar, M., & MacPherson, P. A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.80 · Cited by 22
Mandal, D. P., Lahiry, L., Bhattacharyya, A., Bhattacharyya, S., Sa, G., & Das, T. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.09.005 · Cited by 21
Human T Cell Immunodeficiency: When Signal Transduction Goes Wrong
Grunebaum, E., Sharfe, N., & Roifman, C. M. (2006) · Immunologic Research · doi:10.1385/ir:35:1:117 · Cited by 20
Self-citationJiang, Q., Li, W.-Q., Aiello, F. B., Klarmann, K. D., Keller, J. R., & Durum, S. K. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302558 · Cited by 19
Humanized Immune System (HIS) Mice as a Tool to Study Human NK Cell Development
Huntington, N. D., & Santo, J. P. D. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-75647-7_7 · Cited by 18
IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells
Faller, E. M., Kakal, J. A., Kumar, R., & MacPherson, P. A. (2009) · International Immunology · doi:10.1093/intimm/dxn140 · Cited by 17
Chhabra, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00993 · Cited by 17
Lev, A., Simon, A. J., Barel, O., Eyal, E., Glick‐Saar, E., Nayshool, O., Birk, O. S., Stauber, T., Hochberg, A., Broides, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01672 · Cited by 17
O’Connell, M. J., & McInerney, J. O. (2005) · Journal of Molecular Evolution · doi:10.1007/s00239-004-0313-3 · Cited by 16
Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections
Manickam, C., Shah, S. V., Lucar, O., Ram, D. R., & Reeves, R. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02862 · Cited by 15
Gene Therapy in Infants with Severe Combined Immunodeficiency
Otsu, M., & Candotti, F. (2002) · BioDrugs · doi:10.2165/00063030-200216040-00001 · Cited by 15
Development of a Quantitative Bead Capture Assay for Soluble IL-7 Receptor Alpha in Human Plasma
Faucher, S., Crawley, A. M., Decker, W., Sherring, A., Bogdanovic, D., Ding, T., Bergeron, M., Angel, J. B., & Sandstrom, P. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006690 · Cited by 14
Complete DiGeorge Anomaly in the Absence of Neonatal Hypocalcemia and Velofacial and Cardiac Defects
Al‐Tamemi, S., Mazer, B. D., Mitchell, D., Albuquerque, P., Duncan, A. M. V., McCusker, C. T., & Jabado, N. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0371 · Cited by 12
Suryani, S., & Tangye, S. G. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.55 · Cited by 13
Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection
Shen, T., Chen, X., Xu, Q., Lu, F., & Liu, S. (2010) · Archives of Virology · doi:10.1007/s00705-010-0626-z · Cited by 13
Jo, E., Kook, H., Uchiyama, T., Hakozaki, I., Kim, Y.-O., Song, C., Park, J., Kanegane, H., Tsuchiya, S., & Kumaki, S. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04026 · Cited by 14
Metadata
- Authors
- Roifman, C. M., Zhang, J., Chitayat, D., & Sharfe, N.
- Affiliations
- University of Toronto (CA)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-10-15
- Volume
- 96
- Issue
- 8
- Pages
- 2803-2807
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1510734879
- Cited by
- 177
- References
- 23
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 8 · 2016: 8 · 2015: 5 · 2014: 10 · 2013: 9 · 2012: 10
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- CD127, severe combined immunodeficiency, T cell development, IL-7 signaling, T cell differentiation, B cell development, natural killer cells, proline to serine substitution, consanguinity, antibody deficiency
- MeSH terms
- Agammaglobulinemia, Animals, Antibody Formation, B-Lymphocytes, Cell Differentiation, Cell Line, Transformed, Consanguinity, Enzyme Activation, Herpesvirus 4, Human, Genes, Recessive, Humans, Immunity, Cellular, Infant, Lymphopenia, Male, Pedigree, Phenotype, Phosphorylation, Protein Binding, Protein Processing, Post-Translational, Protein-Tyrosine Kinases, RNA, Messenger, T-Lymphocytes, Transfection, Signal Transduction, Interleukin-7, Bone Marrow Transplantation, Severe Combined Immunodeficiency, Lymphocyte Count, Cell Lineage, COS Cells, Amino Acid Substitution, Mutation, Missense, Receptors, Interleukin-7, Mice, Janus Kinase 3, Interleukin Receptor Common gamma Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review